|
1
|
Duval AJ, Seker-Polat F, Rogozinska M,
Kinali M, Walts AE, Neyisci O, Zhang Y, Li Z, Tanner EJ III, Grubbs
AE, et al: SOX9 drives a stem-like transcriptional state and
platinum resistance in high-grade serous ovarian cancer. J Clin
Invest. 135:e1864672025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hubert CG, Stauffer SR and Lathia JD: A
TOX-ic axis of epigenetic stem cell maintenance and chemoresistance
in colon cancer. PLoS Biol. 21:e30022952023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li F, Si W, Xia L, Yin D, Wei T, Tao M,
Cui X, Yang J, Hong T and Wei R: Positive feedback regulation
between glycolysis and histone lactylation drives oncogenesis in
pancreatic ductal adenocarcinoma. Mol Cancer. 23:902024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J and Yu X, Xiao M, Xu H, Tan Z, Lei
Y, Guo Y, Wang W, Xu J, Shi S and Yu X: Histone lactylation-driven
feedback loop modulates cholesterol-linked immunosuppression in
pancreatic cancer. Gut. 74:1859–1872. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S,
Shen X, Wu Y, Zhang S, Wang X, et al: Lactylome analysis suggests
lactylation-dependent mechanisms of metabolic adaptation in
hepatocellular carcinoma. Nat Metab. 5:61–79. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu R, Ren X, Park YE, Feng H, Sheng X,
Song X, AminiTabrizi R, Shah H, Li L, Zhang Y, et al: Nuclear
GTPSCS functions as a lactyl-CoA synthetase to promote histone
lactylation and gliomagenesis. Cell Metab. 37:377–394.e9. 2025.
View Article : Google Scholar
|
|
7
|
Sun P, Ma L and Lu Z: Lactylation: Linking
the Warburg effect to DNA damage repair. Cell Metab. 36:1637–1639.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng F, Wu J, Chi Q, Wang S, Liu W, Yang
L, Song G, Pan L, Xu K and Wang C: Lactylome analysis unveils
lactylation-dependent mechanisms of stemness remodeling in the
liver cancer stem cells. Adv Sci (Weinh). 11:e24059752024.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv M, Yang X, Xu C, Song Q, Zhao H, Sun T,
Liu J, Zhang Y, Sun G, Xue Y and Zhang Z: SIRT4 promotes pancreatic
cancer stemness by enhancing histone lactylation and epigenetic
reprogramming stimulated by calcium signaling. Adv Sci (Weinh).
12:e24125532025. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gan L, Sui Q, Xu MD, Yang F, Li M, Yuan Y,
Lin Y, Zhang X, Bi G, Jiang W, et al: A tumor-derived lactate/ENO1
lactylation feedback loop facilitates osimertinib resistance of
lung adenocarcinoma. Drug Resist Updat. 85:1013462026. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao X, Li M, Fu Y, Chen C, Chen Y, Xu L,
Bao L, Ma Z, Xu J, Zhou S, et al: PSMD14-mediated PFKFB2
deubiquitination activates H3K27 lactylation to drive cancer
stemness in gastric adenocarcinoma. Cell Death Differ. 33:813–830.
2026. View Article : Google Scholar
|
|
12
|
Zhang D, Tang Z, Huang H, Zhou G, Cui C,
Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al: Metabolic
regulation of gene expression by histone lactylation. Nature.
574:575–580. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liberti MV and Locasale JW: Histone
lactylation: A new role for glucose metabolism. Trends Biochem Sci.
45:179–182. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang D, Gao J, Zhu Z, Mao Q, Xu Z, Singh
PK, Rimayi CC, Moreno-Yruela C, Xu S, Li G, et al: Lysine
L-lactylation is the dominant lactylation isomer induced by
glycolysis. Nat Chem Biol. 21:91–99. 2025. View Article : Google Scholar
|
|
15
|
Moreno-Yruela C, Bæk M, Monda F and Olsen
CA: Chiral post-translational modification to lysine ε-Amino
Groups. Acc Chem Res. 55:1456–1466. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang
B and Zhou F: Alanyl-tRNA synthetase, AARS1, is a lactate sensor
and lactyltransferase that lactylates p53 and contributes to
tumorigenesis. Cell. 187:2375–2392.e33. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z,
Geng D, Yue J, Tang Y, Tian L, et al: The alanyl-tRNA synthetase
AARS1 moonlights as a lactyltransferase to promote YAP signaling in
gastric cancer. J Clin Invest. 134:e1745872024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q,
Huang H, Lu H, Song H, Yang B, et al: AARS1 and AARS2 sense
L-lactate to regulate cGAS as global lysine lactyltransferases.
Nature. 634:1229–1237. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niu Z, Chen C, Wang S, Lu C, Wu Z, Wang A,
Mo J, Zhang J, Han Y, Yuan Y, et al: HBO1 catalyzes lysine
lactylation and mediates histone H3K9la to regulate gene
transcription. Nat Commun. 15:35612024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie B, Zhang M, Li J, Cui J, Zhang P, Liu
F, Wu Y, Deng W, Ma J, Li X, et al: KAT8-catalyzed lactylation
promotes eEF1A2-mediated protein synthesis and colorectal
carcinogenesis. Proc Natl Acad Sci USA. 121:e23141281212024.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu R, Ye X, Lu X, Xiao L, Yuan M, Zhao H,
Guo D, Meng Y, Han H, Luo S, et al: ACSS2 acts as a lactyl-CoA
synthetase and couples KAT2A to function as a lactyltransferase for
histone lactylation and tumor immune evasion. Cell Metab.
37:361–376.e7. 2025. View Article : Google Scholar
|
|
22
|
Zhang C, Zhou T, Li C, Wang D, Tao J, Zhu
X, Lu J, Ni J and Yao YF: Deciphering novel enzymatic and
non-enzymatic lysine lactylation in Salmonella. Emerg Microbes
Infect. 14:24758382025. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moreno-Yruela C, Zhang D, Wei W, Bæk M,
Liu W, Gao J, Danková D, Nielsen AL, Bolding JE, Yang L, et al:
Class I histone deacetylases (HDAC1-3) are histone lysine
delactylases. Sci Adv. 8:eabi66962022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gonzatti MB, Hintzen JCJ, Sharma I, Najar
MA, Tsusaka T, Marcinkiewicz MM, Da Silva Crispim CV, Snyder NW,
Burslem GM and Goldberg EL: Class I histone deacetylases catalyze
lysine lactylation. J Biol Chem. 301:1106022025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsusaka T, Najar MA, Sharma I,
Marcinkiewicz MM, Crispim CVDS, Snyder NW, Burslem GM and Goldberg
EL: Class I histone deacetylases catalyze lysine lactylation.
bioRxiv [Preprint]. 2025.02.25.640220. 2025.
|
|
26
|
Nickel GA, Pederson NJ, Faheem, Yang Z,
Bulf J and Diehl KL: Sirtuin 6 is a histone delactylase. J Biol
Chem. 301:1107952025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen C, Zhang Y, Zang Y, Fan Z, Han Y, Bai
X, Wang A, Zhang J, Wang J and Zhang K: SIRT3 functions as an
eraser of histone H3K9 lactylation to modulate transcription for
inhibiting the progression of esophageal cancer. Mol Cell
Proteomics. 24:1009732025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou L, Liu Z, Peng L, Wu B, Huang Y, Wen
X, Han D, Tan W and Zhou Y: Delactylation of H3K9 by Sirtuin6
inhibits MGMT transcription and reverses temozolomide resistance in
glioblastoma. Int J Biol Macromol. 327:1473322025. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jin J, Bai L, Wang D, Ding W, Cao Z, Yan
P, Li Y, Xi L, Wang Y, Zheng X, et al: SIRT3-dependent
delactylation of cyclin E2 prevents hepatocellular carcinoma
growth. EMBO Rep. 24:e560522023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He X, Li Y, Li J, Li Y, Chen S, Yan X, Xie
Z, Du J, Chen G, Song J and Mei Q: HDAC2-mediated METTL3
delactylation promotes DNA damage repair and chemotherapy
resistance in triple-negative breast cancer. Adv Sci (Weinh).
12:e24131212025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nuñez R, Sidlowski PFW, Steen EA,
Wynia-Smith SL, Sprague DJ, Keyes RF and Smith BC: The TRIM33
bromodomain recognizes histone lysine lactylation. ACS Chem Biol.
19:2418–2428. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhai G, Niu Z, Jiang Z, Zhao F, Wang S,
Chen C, Zheng W, Wang A, Zang Y, Han Y and Zhang K: DPF2 reads
histone lactylation to drive transcription and tumorigenesis. Proc
Natl Acad Sci USA. 121:e24214961212024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei E, Ji D, Jia Y, Sun Z, Gao C, Zeng C,
Wang C, Yu M, Shang G, Xie L, et al: BRD9 recognizes
lactate-induced H3K18 lactylation to drive oncogenic chromatin
remodeling in hepatocellular carcinoma. Cell Death Differ.
33:1946–1959. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bao Q, Wan N, He Z, Cao J, Yuan W, Hao H
and Ye H: Subcellular proteomic mapping of lysine lactylation. J Am
Soc Mass Spectrom. 35:3221–3232. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X,
Miao J, Zhang K, Zhang W, Ma P, et al: Numb/Parkin-directed
mitochondrial fitness governs cancer cell fate via metabolic
regulation of histone lactylation. Cell Rep. 42:1120332023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mao Y, Zhang J, Zhou Q, He X, Zheng Z, Wei
Y, Zhou K, Lin Y, Yu H, Zhang H, et al: Hypoxia induces
mitochondrial protein lactylation to limit oxidative
phosphorylation. Cell Res. 34:13–30. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang B, Jin M, Cui G, Wang Z, Wang F,
Chen M, Zhu L, Li Y, Yang X, Li R, et al: GCN5-ERK
lactylation-phosphorylation loop amplifies lactate-driven cancer
progression. Nat Chem Biol. 22:634–648. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun S, Xu Z, He L, Shen Y, Yan Y, Lv X,
Zhu X, Li W, Tian WY, Zheng Y, et al: Metabolic regulation of
cytoskeleton functions by HDAC6-catalyzed α-tubulin lactylation.
Nat Commun. 15:83772024. View Article : Google Scholar
|
|
39
|
Zhou J, Qiu S, Yang X, Wu Y, Yao X, Hu H,
Luo J, Wijaya CS, Ma L, Long X, et al: Hypoxia-Induced PRMT1
lactylation drives vimentin arginine asymmetric dimethylation in
tumor metastasis. Adv Sci (Weinh). 12:e098612025. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang J, Huang D, Jiang Y, Hou J, Tian M,
Li J, Sun L, Zhang Y, Zhang T, Li Z, et al: Lactate modulates
cellular metabolism through histone lactylation-mediated gene
expression in non-small cell lung cancer. Front Oncol.
11:6475592021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sharma NK and Pal JK: Metabolic ink
lactate modulates epigenomic landscape: A concerted role of
pro-tumor microenvironment and macroenvironment during
carcinogenesis. Curr Mol Med. 21:177–181. 2021. View Article : Google Scholar
|
|
42
|
Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X,
Shao Q, Zhou B, Zhou H, Wei S, et al: Tumor metabolite lactate
promotes tumorigenesis by modulating MOESIN lactylation and
enhancing TGF-β signaling in regulatory T cells. Cell Rep.
39:1109862022. View Article : Google Scholar
|
|
43
|
Yang D, Yin J, Shan L, Yi X, Zhang W and
Ding Y: Identification of lysine-lactylated substrates in gastric
cancer cells. iScience. 25:1046302022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hong H, Chen X, Wang H, Gu X, Yuan Y and
Zhang Z: Global profiling of protein lysine lactylation and
potential target modified protein analysis in hepatocellular
carcinoma. Proteomics. 23:e22004322023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang Y, Luo G, Peng K, Song Y, Wang Y,
Zhang H, Li J, Qiu X, Pu M, Liu X, et al: Lactylation stabilizes
TFEB to elevate autophagy and lysosomal activity. J Cell Biol.
223:e2023080992024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jing F, Zhu L, Zhang J, Zhou X, Bai J, Li
X, Zhang H and Li T: Multi-omics reveals lactylation-driven
regulatory mechanisms promoting tumor progression in oral squamous
cell carcinoma. Genome Biol. 25:2722024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Meng Q, Sun H, Zhang Y, Yang X, Hao S, Liu
B, Zhou H, Xu ZX and Wang Y: Lactylation stabilizes DCBLD1
activating the pentose phosphate pathway to promote cervical cancer
progression. J Exp Clin Cancer Res. 43:362024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Luo Y, Yang Z, Yu Y and Zhang P: HIF1α
lactylation enhances KIAA1199 transcription to promote angiogenesis
and vasculogenic mimicry in prostate cancer. Int J Biol Macromol.
222:2225–2243. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang J, Luo L, Zhao C, Li X, Wang Z, Zeng
Z, Yang X, Zheng X, Jie H, Kang L, et al: A positive feedback loop
between inactive VHL-Triggered histone lactylation and PDGFRβ
signaling drives clear cell renal cell carcinoma progression. Int J
Biol Sci. 18:3470–3483. 2022. View Article : Google Scholar
|
|
50
|
Wang X, Ying T, Yuan J, Wang Y, Su X, Chen
S, Zhao Y, Zhao Y, Sheng J, Teng L, et al: BRAFV600E restructures
cellular lactylation to promote anaplastic thyroid cancer
proliferation. Endocr Relat Cancer. 30:e2203442023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang C, Yu R, Li S, Yuan M, Hu T, Liu J,
Ke H, Ye S, Yun J, Huang J, et al: KRAS mutation increases histone
H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer
progression by facilitating cholesterol transporter GRAMD1A
expression. Cell Death Differ. 32:2225–2238. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gao J, Liu R, Huang K, Li Z, Sheng X,
Chakraborty K, Han C, Zhang D, Becker L and Zhao Y: Dynamic
investigation of hypoxia-induced L-lactylation. Proc Natl Acad Sci
USA. 122:e24048991222025. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zang Y, Wang A, Zhang J, Xia M, Jiang Z,
Jia B, Lu C, Chen C, Wang S, Zhang Y, et al: Hypoxia promotes
histone H3K9 lactylation to enhance LAMC2 transcription in
esophageal squamous cell carcinoma. iScience. 27:1101882024.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Miao Z, Zhao X and Liu X: Hypoxia induced
β-catenin lactylation promotes the cell proliferation and stemness
of colorectal cancer through the wnt signaling pathway. Exp Cell
Res. 422:1134392023. View Article : Google Scholar
|
|
55
|
Xiong J, He J, Zhu J, Pan J, Liao W, Ye H,
Wang H, Song Y, Du Y, Cui B, et al: Lactylation-driven
METTL3-mediated RNA m(6)A modification promotes immunosuppression
of tumor-infiltrating myeloid cells. Mol Cell. 82:1660–1677.e10.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cai J, Zhang P, Cai Y, Zhu G, Chen S, Song
L, Du J, Wang B, Dai W, Zhou J, et al: Lactylation-Driven NUPR1
Promotes Immunosuppression of Tumor-Infiltrating Macrophages in
Hepatocellular Carcinoma. Adv Sci (Weinh). 12:e24130952025.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang
JW, Sun YX, Xu JQ, Liu Q and Long ZJ: STAT5 promotes PD-L1
expression by facilitating histone lactylation to drive
immunosuppression in acute myeloid leukemia. Signal Transduct
Target Ther. 8:3912023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
De Leo A, Ugolini A, Yu X, Scirocchi F,
Scocozza D, Peixoto B, Pace A, D'Angelo L, Liu JKC, Etame AB, et
al: Glucose-driven histone lactylation promotes the
immunosuppressive activity of monocyte-derived macrophages in
glioblastoma. Immunity. 57:1105–1123.e8. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li Z, Liang P, Chen Z, Chen Z, Jin T, He
F, Chen X and Yang K: CAF-secreted LOX promotes PD-L1 expression
via histone Lactylation and regulates tumor EMT through TGFβ/IGF1
signaling in gastric cancer. Cell Signal. 124:1114622024.
View Article : Google Scholar
|
|
60
|
Kong W, He J, Zhou Q, Zhou X, Wei X, Yang
Y, Mei Y, Wang S, Zhang X, Yao B, et al: Histone
lactylation-related genes correlate with the molecular patterns and
functions of cancer-associated fibroblasts and have significant
clinical implications in clear cell renal cell carcinoma. Heliyon.
10:e335542024. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
He J, Li W, Wang S, Lan J, Hong X, Liao L,
Kang D, Wang W, Wang R, Zhang W, et al: Cancer associated
fibroblasts-derived lactate induces oxaliplatin treatment
resistance by promoting cancer stemness via ANTXR1 lactylation in
colorectal cancer. Cancer Lett. 631:2179172025. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang C, Zhou W, Xu H, Xu J, Li J, Liu X,
Lu X, Dai J, Jiang Y, Wang W, et al: Cancer-associated fibroblasts
promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la
positive feedback loop. Oncogene. 44:1400–1414. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li L, Li Z, Meng X, Wang X, Song D, Liu Y,
Xu T, Qin J, Sun N, Tian K, et al: Histone lactylation-derived
LINC01127 promotes the self-renewal of glioblastoma stem cells via
the cis-regulating the MAP4K4 to activate JNK pathway. Cancer Lett.
579:2164672023. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Pan L, Feng F, Wu J, Fan S, Han J, Wang S,
Yang L, Liu W, Wang C and Xu K: Demethylzeylasteral targets lactate
by inhibiting histone lactylation to suppress the tumorigenicity of
liver cancer stem cells. Pharmacol Res. 181:1062702022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhang X, Li Y and Chen Y: Development of a
comprehensive gene signature linking hypoxia, glycolysis,
lactylation, and metabolomic insights in gastric cancer through the
integration of bulk and single-cell RNA-Seq data. Biomedicines.
11:29482023. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lu X, Zhou Z, Qiu P and Xin T: Integrated
single-cell and bulk RNA-sequencing data reveal molecular subtypes
based on lactylation-related genes and prognosis and therapeutic
response in glioma. Heliyon. 10:e307262024. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yu Y, Li Y, Zhou L, Cheng X and Gong Z:
Hepatic stellate cells promote hepatocellular carcinoma development
by regulating histone lactylation: Novel insights from single-cell
RNA sequencing and spatial transcriptomics analyses. Cancer Lett.
604:2172432024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Han R, Chi G, Sun D, Xu Z, Zhou L and Xu
K: Single-cell and spatial transcriptomics reveal
lactylation-associated tumor cell clusters and define a prognostic
risk model in glioblastoma. BMC Cancer. 25:19012025. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie
K, Cao C, Wang Q, Zhao X, Huang Z, et al: Single-cell transcriptome
analysis reveals the association between histone lactylation and
cisplatin resistance in bladder cancer. Drug Resist Updat.
73:1010592024. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li J, Tang C, Zhang X, Xing R and Guo Q:
Histone Lactylation-Driven Upregulation of VRK1 Expression Promotes
Stemness and Proliferation of Glioma Stem Cells. Adv Sci (Weinh).
12:e038972025. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Liu Z, Han J, Su S, Zeng Q, Wu Z, Yuan J
and Yang J: Histone lactylation facilitates MCM7 expression to
maintain stemness and radio-resistance in hepatocellular carcinoma.
Biochem Pharmacol. 236:1168872025. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhang Q, Han Z, Liu JH, Li M, Li W, Zhou X
and Liu X: Hypoxia facilitates stemness of colon cancer cells via
histone lactylation. Biochim Biophys Acta Mol Basis Dis.
1871:1679932025. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Nguyen NTB, Gevers S, Kok RNU, Burgering
LM, Neikes H, Akkerman N, Betjes MA, Ludikhuize MC, Gulersonmez C,
Stigter ECA, et al: Lactate controls cancer stemness and plasticity
through epigenetic regulation. Cell Metab. 37:903–919.e10. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Qiao Z, Li Y, Li S, Liu S and Cheng Y:
Hypoxia-induced SHMT2 protein lactylation facilitates glycolysis
and stemness of esophageal cancer cells. Mol Cell Biochem.
479:3063–3076. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li Q, Lin G, Zhang K, Liu X, Li Z, Bing X,
Nie Z, Jin S, Guo J and Min X: Hypoxia exposure induces lactylation
of Axin1 protein to promote glycolysis of esophageal carcinoma
cells. Biochem Pharmacol. 226:1164152024. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yan F, Teng Y, Li X, Zhong Y, Li C, Yan F
and He X: Hypoxia promotes non-small cell lung cancer cell
stemness, migration, and invasion via promoting glycolysis by
lactylation of SOX9. Cancer Biol Ther. 25:23041612024. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhao S, Cheng J, Zhou G, Tao L, Xing J,
Liu L, Chen Z and Song P: Histone lactylation-driven YTHDF2
promotes non-small cell lung cancer cell glycolysis and stemness by
recognizing m6A modification of SFRP2. Biochem Pharmacol.
240:1170972025. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yuan Q, Zhang H, Zhang N, Qian Y, Hong Z,
Wan X, Ye R, Chen D, Feng X, Yu G and Niu M: BPHL promotes TNBC
stemness by resolving R-loops via POLR2A lactylation inhibition and
BARD1-mediated ubiquitination. Cancer Lett. 645:2183882026.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Fiaschi T, Giannoni E, Taddei ML, Cirri P,
Marini A, Pintus G, Nativi C, Richichi B, Scozzafava A, Carta F, et
al: Carbonic anhydrase IX from cancer-associated fibroblasts drives
epithelial-mesenchymal transition in prostate carcinoma cells. Cell
Cycle. 12:1791–1801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Chen S, Huang G, Guo Z, Guo Z, Cao C, Zhao
G, Lubamba GP, Huang Y, Yang J, Lian H, et al: Tumor-associated
Schwann cells promote salivary adenoid cystic carcinoma stem-like
reprogramming via IGF2/IGF1R induced histone H3 lysine 18
lactylation. Cancer Lett. 628:2178472025. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Shi L, Li B, Tan J, Zhu L, Zhang S, Zhang
Y, Xiang M, Li J, Chen Y, Han X, et al: Exosomal lncRNA Mir100hg
from lung cancer stem cells activates H3K14 lactylation to enhance
metastatic activity in non-stem lung cancer cells. J
Nanobiotechnology. 23:1562025. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang D, Du G, Chen X, Wang J, Liu K, Zhao
H, Cheng C, He Y, Jing N, Xu P, et al: Zeb1-controlled metabolic
plasticity enables remodeling of chromatin accessibility in the
development of neuroendocrine prostate cancer. Cell Death Differ.
31:779–791. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhou Z, Yin X, Sun H, Lu J, Li Y, Fan Y,
Lv P, Han M, Wu J, Li S, et al: PTBP1 Lactylation Promotes Glioma
Stem Cell Maintenance through PFKFB4-Driven Glycolysis. Cancer Res.
85:739–757. 2025. View Article : Google Scholar
|
|
84
|
Tang X, Liu Y, Yang C, Zhang H, Zhang G,
Wang Q, Jiang S, Gao X, Liu Y and Dong Y: Deciphering the
lactylation landscape in glioma: a novel gene signature predicts
patient survival and immunotherapy sensitivity. Front Immunol.
16:16643472025. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yao G and Yang Z: Glypican-3 knockdown
inhibits the cell growth, stemness, and glycolysis development of
hepatocellular carcinoma cells under hypoxic microenvironment
through lactylation. Arch Physiol Biochem. 130:546–554. 2024.
|
|
86
|
Liu Y, Chen J, Ma L, Zhao S, Hui X, Xiong
W, Cheng S and Zhang Y: ZMIZ1 lactylation induces tamoxifen
resistance in breast cancer through increasing transcriptional
activity of Nanog to impact cell stemness and cholesterol uptake.
Cell Biol Toxicol. 41:1172025. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Deng J, Li Y, Yin L, Liu S, Li Y, Liao W,
Mu L, Luo X and Qin J: Histone lactylation enhances GCLC expression
and thus promotes chemoresistance of colorectal cancer stem cells
through inhibiting ferroptosis. Cell Death Dis. 16:1932025.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhao Y, Liu W, Deng K, Chen Y, Zhou P, Liu
C, Jiang G, Wu J, Zhang Y, Qu H, et al: LncRNA BASP1-AS1 drives
PCBP2 K115 lactylation to suppress ferroptosis and confer
oxaliplatin resistance in gastric cancer. Free Radic Biol Med.
240:717–734. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Gao M, Wang S, Huang Z, Wang T and Yu Y:
H3K18la Facilitates TRA2A-Mediated alternative splicing of STIL,
suppressing ferroptosis and cisplatin treatment sensitivity in
ovarian cancer. Cancer Res Treat. 58:1428–1448. 2026. View Article : Google Scholar :
|
|
90
|
Sun C, Li X, Teng Q, Liu X, Song L,
Schiöth HB, Wu H, Ma X, Zhang Z, Qi C, et al: Targeting
platinum-resistant ovarian cancer by disrupting histone and RAD51
lactylation. Theranostics. 15:3055–3075. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, Luo
X, Yang T, Zhang M, Zuo B, Zeng T, et al: Histone H3K9 lactylation
confers temozolomide resistance in glioblastoma via LUC7L2-Mediated
MLH1 intron retention. Adv Sci (Weinh). 11:e23092902024. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Dai J, Lu X, Zhang C, Qu T, Li W, Su J,
Guo R, Yin D, Wu P, Han L and Zhang E: NNMT promotes acquired
EGFR-TKI resistance by forming EGR1 and lactate-mediated double
positive feedback loops in non-small cell lung cancer. Mol Cancer.
24:792025. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Li A, Gong Z, Long Y, Li Y, Liu C, Lu X,
Li Q, He X, Lu H, Wu K, et al: Lactylation of LSD1 is an acquired
epigenetic vulnerability of BRAFi/MEKi-resistant melanoma. Dev
Cell. 60:1974–1990.e11. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan
Y, Wu Y, Zhao J, Shang C, Liang H and Zhang W: Lactylation-Driven
IGF2BP3-Mediated serine metabolism reprogramming and RNA
m6A-Modification promotes lenvatinib resistance in HCC. Adv Sci
(Weinh). 11:e24013992024. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Dong R, Fei Y, He Y, Gao P, Zhang B, Zhu
M, Wang Z, Wu L, Wu S, Wang X, et al: Lactylation-Driven HECTD2
Limits the Response of Hepatocellular Carcinoma to Lenvatinib. Adv
Sci (Weinh). 12:e24125592025. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zeng Y, Jiang H, Chen Z, Xu J, Zhang X,
Cai W, Zeng X, Ma P, Lin R, Yu H, et al: Histone lactylation
promotes multidrug resistance in hepatocellular carcinoma by
forming a positive feedback loop with PTEN. Cell Death Dis.
16:592025. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chen HJ, Yu MM, Huang JC, Lan FY, Liao HH,
Xu ZH, Yu YJ, Huang YC and Chen F: SLC4A4 is a novel driver of
enzalutamide resistance in prostate cancer. Cancer Lett.
597:2170702024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sun R, Huang Y, He H, Li Q, Wang L, Zhang
G, Wei Z, Cao Y, Li J, Wang X, et al: KDM5B-driven glucose
metabolic reprogramming promotes enzalutamide resistance in
prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis. Mol
Cancer. 25:972026. View Article : Google Scholar
|
|
99
|
Tong H, Jiang Z, Song L, Tan K, Yin X, He
C, Huang J, Li X, Jing X, Yun H, et al: Dual impacts of
serine/glycine-free diet in enhancing antitumor immunity and
promoting evasion via PD-L1 lactylation. Cell Metab. 38:2472026.
View Article : Google Scholar
|
|
100
|
Liu S, Pan Y, Liu W, Bu X, Shao R, Wang Q,
Wu J, Wu C, Hu W, Xu J, et al: Lactylation-driven MVP upregulation
boosts immunotherapy resistance by inhibiting PD-L1 degradation in
hepatocellular carcinoma. J Immunother Cancer. 13:e0122302025.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Chen Q, Yuan H, Bronze MS and Li M:
Targeting lactylation and the STAT3/CCL2 axis to overcome
immunotherapy resistance in pancreatic ductal adenocarcinoma. J
Clin Invest. 135:e1914222025. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sun K, Zhang X, Shi J, Huang J, Wang S, Li
X, Lin H, Zhao D, Ye M, Zhang S, et al: Elevated protein
lactylation promotes immunosuppressive microenvironment and
therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin
Invest. 135:e1870242025. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Wang R, Li C, Cheng Z, Li M, Shi J, Zhang
Z, Jin S and Ma H: H3K9 lactylation in malignant cells facilitates
CD8(+) T cell dysfunction and poor immunotherapy response. Cell
Rep. 43:1146862024. View Article : Google Scholar
|
|
104
|
Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren
H and Zheng L: H3K18 Lactylation potentiates immune escape of
non-small cell lung cancer. Cancer Res. 84:3589–3601. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chao J, Chen GD, Huang ST, Gu H, Liu YY,
Luo Y, Lin Z, Chen ZZ, Li X, Zhang B, et al: High histone H3K18
lactylation level is correlated with poor prognosis in epithelial
ovarian cancer. Neoplasma. 71:319–332. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhao Y, Xing Z, Zhao Y, Xu H, Liu R, Yang
T, Wang Y and Zhu X: Lactylation prognostic signature identifies
DHCR7 as a modulator of chemoresistance and immunotherapy efficacy
in bladder cancer. Front Immunol. 16:15857272025. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yang X, Li G, Jiang R, Yang Y, Zhu H,
Huang L, Li T, Zhou J and Liu Z: Lactylation-related gene
signatures for prognosis and treatment response prediction in
radiation-resistant non-small cell lung cancer. Discov Oncol.
16:17872025. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Hu H, Peng F, Ba Q, Hu W and Lu Y:
Integrative machine learning identifies lactylation-related gene
signature prognostic for chemotherapeutic efficacy in colorectal
carcinoma. Discov Oncol. 17:692025. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao
H, Zhao F, Wang Z, Yang X, Jin M, et al: Metabolic regulation of
homologous recombination repair by MRE11 lactylation. Cell.
187:294–311.e21. 2024. View Article : Google Scholar
|
|
110
|
Yang Z, Su W, Zhang Q, Niu L, Feng B,
Zhang Y, Huang F, He J, Zhou Q, Zhou X, et al: Lactylation of HDAC1
confers resistance to ferroptosis in colorectal cancer. Adv Sci
(Weinh). 12:e24088452025. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Fu Q, Cat A and Zheng YG: New histone
lysine acylation biomarkers and their roles in epigenetic
regulation. Curr Protoc. 3:e7462023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Sun L, Zhang Y, Yang B, Sun S, Zhang P,
Luo Z, Feng T, Cui Z, Zhu T, Li Y, et al: Lactylation of METTL16
promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric
cancer. Nat Commun. 14:65232023. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Rao K, Zhang X, Luo Y, Xia Q, Jin Y and He
J: Lactylation orchestrates ubiquitin-independent degradation of
cGAS and promotes tumor growth. Cell Rep. 44:1154412025. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lao Y, Jin Y, Wu S, Fang T, Wang Q, Sun L
and Sun B: Deciphering a profiling based on multiple
post-translational modifications functionally associated regulatory
patterns and therapeutic opportunities in human hepatocellular
carcinoma. Mol Cancer. 23:2832024. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Chen S, Li Y, Hu J, Li H, Hu C, Zhao J,
Qian H, Bai S, Tang Z and Feng Y: Integrating bulk RNA-seq,
scRNA-seq, and spatial transcriptomics data to identify novel
post-translational modification-related molecular subtypes and
therapeutic responses in hepatocellular carcinoma. Cancer Cell Int.
25:3302025. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Krishnamoorthy G, Kaiser P, Abu Abed U,
Weiner J III, Moura-Alves P, Brinkmann V and Kaufmann SHE: FX11
limits Mycobacterium tuberculosis growth and potentiates
bactericidal activity of isoniazid through host-directed activity.
Dis Model Mech. 13:dmm0419542020. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Sun T, Liu B, Li Y, Wu J, Cao Y, Yang S,
Tan H, Cai L, Zhang S, Qi X, et al: Oxamate enhances the efficacy
of CAR-T therapy against glioblastoma via suppressing
ectonucleotidases and CCR8 lactylation. J Exp Clin Cancer Res.
42:2532023. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ge H, Malsiu F, Gao Y, Losmanova T, Blank
F, Ott J, Medová M, Peng RW, Deng H, Dorn P and Marti TM:
Inhibition of LDHB suppresses the metastatic potential of lung
cancer by reducing mitochondrial GSH catabolism. Cancer Lett.
611:2173532025. View Article : Google Scholar
|
|
119
|
Lopez E, Karattil R, Nannini F, Weng-Kit
Cheung G, Denzler L, Galvez-Cancino F, Quezada S and Pule MA:
Inhibition of lactate transport by MCT-1 blockade improves chimeric
antigen receptor T-cell therapy against B-cell malignancies. J
Immunother Cancer. 11:e0062872023. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Saulle E, Spinello I, Quaranta MT,
Pasquini L, Pelosi E, Iorio E, Castelli G, Chirico M, Pisanu ME,
Ottone T, et al: Targeting lactate metabolism by inhibiting MCT1 or
MCT4 impairs leukemic cell proliferation, induces two different
related death-pathways and increases chemotherapeutic sensitivity
of acute myeloid leukemia cells. Front Oncol. 10:6214582021.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Bridgewater HE, Bolitho EM, Romero-Canelón
I, Sadler PJ and Coverdale JPC: Targeting cancer lactate metabolism
with synergistic combinations of synthetic catalysts and
monocarboxylate transporter inhibitors. J Biol Inorg Chem.
28:345–353. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Chen ZX, Liu MD, Guo DK, Zou MZ, Wang SB,
Cheng H, Zhong Z and Zhang XZ: A MSN-based tumor-targeted
nanoplatform to interfere with lactate metabolism to induce tumor
cell acidosis for tumor suppression and anti-metastasis. Nanoscale.
12:2966–2972. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hu M, Zhao Y, Cao Y, Tang Q, Feng Z, Ni J
and Zhou X: DRP1 promotes lactate utilization in KRAS-mutant
non-small-cell lung cancer cells. Cancer Sci. 111:3588–3599. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Khamoui AV, Tokmina-Roszyk D, Rossiter HB,
Fields GB and Visavadiya NP: Hepatic proteome analysis reveals
altered mitochondrial metabolism and suppressed acyl-CoA
synthetase-1 in colon-26 tumor-induced cachexia. Physiol Genomics.
52:203–216. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zeng Z, Lan J, Lei S, Yang Y, He Z, Xue Y
and Chen T: Simultaneous inhibition of ornithine decarboxylase 1
and pyruvate kinase M2 exerts synergistic effects against
hepatocellular carcinoma cells. Onco Targets Ther. 13:11697–11709.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Qin X, Zhang M, Hu X, Du Q, Zhao Z, Jiang
Y and Luan Y: Nanoengineering of a newly designed chlorin e6
derivative for amplified photodynamic therapy via regulating
lactate metabolism. Nanoscale. 13:11953–11962. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zhang Y, Li L, Li Y, Fei Y, Xue C, Yao X,
Zhao Y, Wang X, Li M and Luo Z: An ROS-activatable nanoassembly
remodulates tumor cell metabolism for enhanced ferroptosis therapy.
Adv Healthc Mater. 11:e21017022022. View Article : Google Scholar
|
|
128
|
Zhang F, Gu T, Li J, Zhu Y, Chu M, Zhou Q
and Liu J: Emodin regulated lactate metabolism by inhibiting MCT1
to delay non-small cell lung cancer progression. Hum Cell.
38:112024. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Xu H, Li L, Wang S, Wang Z, Qu L, Wang C
and Xu K: Royal jelly acid suppresses hepatocellular carcinoma
tumorigenicity by inhibiting H3 histone lactylation at H3K9la and
H3K14la sites. Phytomedicine. 118:1549402023. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yu Y, Huang X, Liang C and Zhang P:
Evodiamine impairs HIF1A histone lactylation to inhibit
Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in
prostate cancer. Eur J Pharmacol. 957:1760072023. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Li M, Zhu T, Jiang F, Zhang W, Gao Y, Shen
M, Yu J and Zheng J: Ginsenoside Rk1 suppresses the
epithelial-mesenchymal transition of hepatic stellate cells via
PFKFB2-mediated aerobic glycolysis. Chem Biol Interact.
421:1117602025. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Kumstel S, Schreiber T, Goldstein L,
Stenzel J, Lindner T, Joksch M, Zhang X, Wendt EHU, Schönrogge M,
Krause B, et al: Targeting pancreatic cancer with combinatorial
treatment of CPI-613 and inhibitors of lactate metabolism. PLoS
One. 17:e02666012022. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zhang Y, Wu X, Wang K, Tang Y, Lu X, Sun
F, Tang H, Chen X and Ning S: Simultaneous reversal of T
lymphocytes and cancer cells metabolism via a biomimetic
heavy-atom-free photosensitizers-based combination therapies to
boost cancer photoimmunotherapy. Adv Sci (Weinh). 12:e24161432025.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Deng X, Zhu Y, Dai Z, Liu Q, Song Z, Liu
T, Huang Y and Chen H: A Bimetallic Nanomodulator to Reverse
Immunosuppression via Sonodynamic-Ferroptosis and Lactate
Metabolism Modulation. Small. 20:e24045802024. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Li Y, Wei Y, Ma S, Li F, Meng X and Yu S:
A dual-transformable MgGa-MOF nanoplatform for HCC therapy via
lactate metabolism blockade and immune reactivation. J
Nanobiotechnology. 24:4522026. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Cheng Z, Huang H, Li M, Liang X, Tan Y and
Chen Y: Lactylation-related gene signature effectively predicts
prognosis and treatment responsiveness in hepatocellular carcinoma.
Pharmaceuticals (Basel). 16:6442023. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan
M, Xiang J, He N, Hu Z and Wang F: CircXRN2 suppresses tumor
progression driven by histone lactylation through activating the
Hippo pathway in human bladder cancer. Mol Cancer. 22:1512023.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Wu Q, Li X, Long M, Xie X and Liu Q:
Integrated analysis of histone lysine lactylation (Kla)-specific
genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic
targets for hepatocellular carcinoma. Sci Rep. 13:186422023.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Wu X: In-depth discovery of protein
lactylation in hepatocellular carcinoma. Proteomics,.
23:e23000032023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Shao C, Tang S, Yu S, Liu C, Zhang Y, Wan
T, He Z, Yuan Q, Wu S, Zhang H, et al: Genetic code expansion
reveals site-specific lactylation in living cells reshapes protein
functions. Nat Commun. 16:2272025. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Wang X, Liu X, Xiao R, Fang Y, Zhou F, Gu
M, Luo X, Jiang D, Tang Y, You L and Zhao Y: Histone lactylation
dynamics: Unlocking the triad of metabolism, epigenetics, and
immune regulation in metastatic cascade of pancreatic cancer.
Cancer Lett. 598:2171172024. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu
H, Yin S, Chen Q, Xie X, Ren X, et al: Metabolic recoding of
NSUN2-Mediated m(5)C modification promotes the progression of
colorectal cancer via the NSUN2/YBX1/m(5)C-ENO1 positive feedback
loop. Adv Sci (Weinh). 11:e23098402024. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Liu J, Du J, Li Y, Wang F, Song D, Lin J,
Li B and Li L: Catalpol induces apoptosis in breast cancer in vitro
and in vivo: Involvement of mitochondria apoptosis pathway and
post-translational modifications. Toxicol Appl Pharmacol.
454:1162152022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Lai FL and Gao F: Auto-Kla: a novel web
server to discriminate lysine lactylation sites using automated
machine learning. Brief Bioinform. 24:bbad0702023. View Article : Google Scholar : PubMed/NCBI
|